Fendiline, an L-type calcium channel blocker (IC50 value of 17 µM), is a specific inhibitor of K-Ras plasma membrane targeting (IC50 value of 9.64 µM) with no detectable effect on the localization of H- and N-Ras. Moreover, Fendiline blocked the proliferation of pancreatic, colon, lung, and endometrial cancer cell lines expressing oncogenic mutant K-Ras.

KEYWORDS: Fendiline hydrochloride | supplier | KRAS inhibitor | CAS [13636-18-5] | [13042-18-7] | GTP | KRAS | Inhibitor | Enzymes | Calcium Channel blocker | Ca2+ | GTPase | K-Ras